Investing Profile

Asish Xavier

InvestorVC
Vice President, Venture Investments at Johnson & Johnson Innovation - JJDC, Inc
jnjinnovation.com/team/asish-...South San Francisco, California
Photo of Asish Xavier, Investor at Johnson & Johnson Innovation

Signal uses Gmail to reveal intro paths. Email content is never read.

Sign in with Google →
University of Pennsylvania - The Wharton School Network
226 CONNECTIONS
The Johns Hopkins University Network
67 CONNECTIONS
Johnson & Johnson Network
27 CONNECTIONS
Johnson & Johnson Network
27 CONNECTIONS
Johnson & Johnson Network
27 CONNECTIONS
cb
$100K - $5.0M
$1.5M
21
CompanyStageDateRound SizeTotal Raised
SonoThera
Series ADec 2022$61M
$61M
Co-investors: Lori Hu (Vertex Ventures), Tom Willis (Illuminate Ventures), Brian Halak (Medical Excellence Capital, LLC), Steven Gillis (ARCH Venture Partners), Lu Wang (Foothill Ventures (formerly Tsingyuan Ventures))
PhaseBio Pharmaceuticals
Series CMar 2015$40M
Series BJun 2012$23M
Series BJan 2010$25M
Series UnknownOct 2007$7M
$130M
Co-investors: Robert Ingram (Hatteras Venture Partners), Justin Klein (Vensana Capital), James Barrett
Aduro BioTech
Series CJun 2014$56M
$56M
ViaCyte
Series CJul 2013$11M
Series CJul 2007$25M
Series UnknownMay 2006$20M
$140M
Co-investors: Heath Lukatch (Red Tree Venture Capital), Adam Koppel (Bain Capital Life Sciences)
Protagonist Therapeutics
Series BJun 2013$14M
$54M
Co-investors: Julie Grant (Canaan Partners)
Aquinox Pharmaceuticals
Series CApr 2013$18M
Series BJun 2010$25M
Series AJun 2007$15M
$58M
Gyre Therapeutics
Post Ipo EquityApr 2013$5M
Post Ipo EquitySep 2012$13M
Post Ipo EquityDec 2008$40M
$88M
Co-investors: Nassim Usman (Morgenthaler Ventures), Ralph (Chris) Christoffersen (Morgenthaler Ventures)
Nevro
Series CMar 2013$48M
Series BJul 2011$58M
$130M
Co-investors: Peter Bisgaard (Pivotal bioVenture Partners), Paul Klingenstein (Aberdare Ventures)
Board Observer Pipeline Therapeutics2023 - Present
Member Board of Directors SonoThera2022 - Present
Member Board Of Directors Verana Health2021 - Present
Member Board Of Directors Paige2021 - Present
Investor Legend Biotech2020 - Present
J&J Innovation - JJDC, Vice President, Venture Investments Johnson & Johnson2007 - Present
Member Board of Directors XWPharma 凯瑞康宁2019 - 2023
Member Board of Directors ESCAPE Bio2015 - 2022
Member Board of Directors ViaCyte2007 - 2022
Member Board of Directors Cue Health Inc.2020 - 2021
Board Observer Datavant2020 - 2021
Member Board of Directors Accelerator Life Science Partners2014 - 2021
Member Board of Directors Adicet Bio, Inc2019 - 2020
Member Board Of Directors Fusion Pharmaceuticals2017 - 2020
Member Board of Directors BlackThorn Therapeutics2015 - 2020
Member Board of Directors PhaseBio Pharmaceuticals, Inc.2009 - 2017
Member Board of Directors Protagonist Therapeutics2013 - 2016
Board Observer Aduro Biotech, Inc.2014 - 2015
Member Board of Directors Catalyst Biosciences2007 - 2015
Member Board of Directors Celladon Corporation2007 - 2014
Board Observer Nevro2011 - 2014
Member Board of Directors Genocea Biosciences2010 - 2014
Member Board of Directors Aquinox Pharmaceuticals, Inc.2006 - 2014
Member Board of Directors Aldeyra Therapeutics2005 - 2014
Board Observer Five Prime Therapeutics, Inc.2006 - 2013
Member Board of Directors Navitor Pharmaceuticals2009 - 2012
Principal, Venture Investments Johnson & Johnson2006 - 2007
Senior Associate, Venture Investments Johnson & Johnson2004 - 2006
Manager, Business Development BioRexis Pharmaceuticals Corporation2003 - 2004
Group Leader, R&D Message Pharmaceuticals1999 - 2001
University of Pennsylvania - The Wharton School MBA
The Johns Hopkins University Postdoctoral Fellow
University of Houston Ph.D.
Indian Institute of Technology, Kanpur B.Tech.